These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6861089)

  • 21. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic radical cystoprostatectomy: our experience in a consecutive series of 10 patients with a 3 years follow-up.
    Simonato A; Gregori A; Lissiani A; Bozzola A; Galli S; Gaboardi F
    Eur Urol; 2005 Jun; 47(6):785-90; discussion 790-2. PubMed ID: 15925074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Instillation therapy in superficial urinary bladder cancer. Finnbladder Group.
    Jauhiainen KE; Alfthan OS
    Scand J Urol Nephrol Suppl; 1991; 138():179-85. PubMed ID: 1785001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy.
    Wang P; Luo JD; Wu WF; Wang S; Cai SL; Shen BH; Shi SF; Wei KX; Zhang ZG; Chen ZD
    Braz J Med Biol Res; 2007 Jul; 40(7):979-84. PubMed ID: 17653452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of early treatment of transitional cell carcinoma of prostatic ducts.
    Wishnow KI; Ro JY
    Urology; 1988 Jul; 32(1):11-2. PubMed ID: 3388655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of BCG in T1G3 bladder transitional cell carcinoma (TCC): our experience].
    Comeri GC; Belvisi P; Conti G; Cretarola E; Duvia R; Furgoni R; Gianneo E; Radice GP
    Arch Ital Urol Androl; 1996 Feb; 68(1):55-9. PubMed ID: 8664924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radical cystectomy in the treatment of bladder cancer always in due time?].
    May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
    Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management.
    Solsona E; Iborra I; Ricós JV; Dumont R; Casanova JL; Calabuig C
    Urology; 1997 Mar; 49(3):347-52. PubMed ID: 9123696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium.
    Manyak MJ; Ogan K
    J Endourol; 2003 Oct; 17(8):633-9. PubMed ID: 14622483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of a second transurethral resection for T1 bladder cancer.
    Schwaibold HE; Sivalingam S; May F; Hartung R
    BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
    Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
    J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction.
    Freeman JA; Esrig D; Stein JP; Simoneau AR; Skinner EC; Chen SC; Groshen S; Lieskovsky G; Boyd SD; Skinner DG
    Cancer; 1995 Sep; 76(5):833-9. PubMed ID: 8625187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
    Byrne RR; Shariat SF; Brown R; Kattan MW; Morton RA JR; Wheeler TM; Lerner SP
    J Urol; 2001 May; 165(5):1473-9. PubMed ID: 11342899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservative treatment of high grade superficial bladder tumours.
    Trinchieri A; Bonacina P; Butti A; Cappoli S; Esposito N; Invernizzi S; Librizzi A; Locatelli G
    Arch Ital Urol Androl; 2005 Dec; 77(4):215-8. PubMed ID: 16444936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy.
    Matsumoto K; Shariat SF; Casella R; Wheeler TM; Slawin KM; Lerner SP
    J Urol; 2003 Dec; 170(6 Pt 1):2248-52. PubMed ID: 14634390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
    Clark PE; Stein JP; Groshen SG; Cai J; Miranda G; Lieskovsky G; Skinner DG
    Cancer; 2005 Feb; 103(3):546-52. PubMed ID: 15630702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.